Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Toyomi Kamesaki"'
Publikováno v:
Case Reports in Rheumatology, Vol 2015 (2015)
A 57-year-old man with rheumatoid arthritis developed severe anemia during treatment with adalimumab plus methotrexate. Cold agglutinin disease was diagnosed because haptoglobin was undetectable, cold agglutinin was positive (1 : 2048), and the direc
Externí odkaz:
https://doaj.org/article/bd0b203311ee4e09805a78fb09f49c65
Autor:
Toyomi Kamesaki
Publikováno v:
Transfusion. 62:205-216
BACKGROUND Approximately 5%-10% of autoimmune hemolytic anemia (AIHA) cases are negative for direct antiglobulin test (DAT). We previously reported a classification system for untreated patients with DAT-negative AIHA by quantifying levels of red blo
Publikováno v:
Medicine: Case Reports and Study Protocols. 4:e0278
Autor:
Akihito Kitao, Keiji Kurata, Toyomi Kamesaki, Takashi Yamasaki, Yoshihiro Kakeji, Shinichiro Kawamoto, Hironobu Minami, Yasuo Sumi, Hiroshi Matsuoka, Ikuyo Hayakawa
Publikováno v:
International Journal of Hematology. 111(5):657-666
Autoimmune hemolytic anemia (AIHA) is a rare comorbidity in colorectal cancer (CRC) and has an unknown etiology. Previously, we described an AIHA case secondary to CRC with ectopic band 3 expression. Herein, we investigated ectopic band 3 expression
Autor:
Toyomi, Kamesaki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(5)
About 5-10% of patients with autoimmune hemolytic anemia (AIHA) and a negative result on the direct antiglobulin test (DAT) are difficult to diagnose. Most of these patients with AIHA have red blood cell-associated IgG levels below the cut-off value
Autor:
Akihito Kitao, Kazuo Hatanaka, Shinichiro Kawamoto, Ryota Masutani, Toshiharu Tamaki, Takayuki Takubo, Masami Imakita, Toyomi Kamesaki
Publikováno v:
Human Pathology. 83:193-198
Cancer patients occasionally have anemia with high mean corpuscular volume in addition to iron deficiency anemia. Secondary autoimmune hemolytic anemia (AIHA) following cancer is also observed with low frequency. To date, no causal mechanisms for the
Autor:
Toyomi Kamesaki, Jaime Morales, Hideho Wada, Elisa Tsao, Junichi Nishimura, Yuzuru Kanakura, Eric Yu
Publikováno v:
International journal of hematology. 112(3)
Cold agglutinin disease (CAD) is a rare, complement-mediated autoimmune hemolytic anemia. Patients with CAD in the United States and Europe have an increased incidence of thromboembolism (TE), but comparable information for patients in other regions
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 64:534-539
Publikováno v:
The Kitakanto Medical Journal. 67:323-328
Autor:
Toyomi, Kamesaki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(9)
In 2017, The British Society of Haematology published new guidelines for the diagnosis and management of autoimmune hemolytic anemia (AIHA). Usually this is diagnosed using a combination of clinical and laboratory findings of hemolysis using the dire